超越状或体下深层大脑刺激来治疗 dystonia
Vedant Garg1, Venkat Srikar Lavu1, Grace Hey1
1Department of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA.
研究人员正在探索新的深度大脑刺激 (DBS) 目标,以超越亚thalamic 核和全球白内部的 dystonia. 本综述涵盖了新的DBS目标和非侵入性研究,以改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 神经科学是一个神经科学.
背景情况:
- 脑下核和内球的深度大脑刺激 (DBS) 是FDA批准的 dystonia 治疗.
- 虽然有效,但对于 dystonia 的 DBS 结果在患者之间有很大差异.
- 这种变异性需要探索替代的神经调节点,以获得更一致的结果.
研究的目的:
- 审查临床前和临床数据的新型深度大脑刺激的目标为 dystonia.
- 探索与 dystonia 的病理电路相关的非侵入性神经调节研究.
主要方法:
- 关于 dystonia 新型 DBS 目标的临床前和临床研究的文献综述.
- 在 dystonia 的非侵入性神经调节研究的分析.
主要成果:
- 确定了几个有前途的新目标DBS在dystonia.
- 突出了对非侵入性神经调节的新兴研究,以了解 dystonia 电路.
结论:
- 新的DBS目标显示了改善 dystonia 治疗一致性的潜力.
- 对这些目标和非侵入性技术的进一步研究可能会提高 dystonia 患者的治疗结果.
更多相关视频
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Skeletal Muscle Relaxants: Therapeutic Uses
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Parkinson's Disease: Overview
